Mark Leschly's most recent trade in ChargePoint Holdings Inc - Ordinary Shares - Class A was a trade of 254,785 Common Stock done . Disclosure was reported to the exchange on July 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ChargePoint Holdings Inc -... | Mark Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2025 | 254,785 | 427,517 | - | 0 | Common Stock | |
| ChargePoint Holdings Inc -... | Mark Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2024 | 115,552 | 172,732 | - | 0 | Common Stock | |
| ChargePoint Holdings Inc -... | Mark Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 21,925 | 57,180 | - | 0 | Common Stock | |
| ChargePoint Holdings Inc -... | Mark Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2022 | 13,563 | 35,255 | - | 0 | Common Stock | |
| ChargePoint Holdings Inc -... | Mark Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2021 | 3,192 | 21,692 | - | 0 | Common Stock | |
| ChargePoint Holdings Inc -... | Mark Leschly | Director | Other type of transaction at price $ 0.00 per share. | 01 Jul 2021 | 12,650 | 420,946 | - | 0 | Common Stock | |
| Ngm Biopharmaceuticals Inc | Mark Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 19,619 | 19,619 | - | - | Stock Option (Right to Buy) | |
| ChargePoint Holdings Inc -... | Mark Leschly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2021 | 18,500 | 18,500 | - | 0 | Common Stock |